| |
Latest 10 SEC filings (by transaction date) for BIAF within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 24/24 | Apr 8/24 | Zannes Maria | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -64,848 | |
Apr 24/24 | Apr 8/24 | Zannes Maria | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -28,264 | $2.65 |
Apr 24/24 | Apr 8/24 | Zannes Maria | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 64,848 | $1.16 |
Apr 24/24 | Apr 4/24 | Zannes Timothy P | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -64,848 | |
Apr 24/24 | Apr 4/24 | Zannes Timothy P | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -29,031 | $2.58 |
Apr 24/24 | Apr 4/24 | Zannes Timothy P | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 64,848 | $1.16 |
Apr 24/24 | Apr 3/24 | Girgenti Steven | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -64,848 | |
Apr 24/24 | Apr 3/24 | Girgenti Steven | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -33,438 | $2.24 |
Apr 24/24 | Apr 3/24 | Girgenti Steven | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 64,848 | $1.16 |
Mar 29/24 | Feb 26/24 | Anderson Robert A. | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -64,848 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for BIAF within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 24/24 | Apr 8/24 | Zannes Maria | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -64,848 | |
Apr 24/24 | Apr 8/24 | Zannes Maria | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -28,264 | $2.65 |
Apr 24/24 | Apr 8/24 | Zannes Maria | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 64,848 | $1.16 |
Apr 24/24 | Apr 4/24 | Zannes Timothy P | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -64,848 | |
Apr 24/24 | Apr 4/24 | Zannes Timothy P | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -29,031 | $2.58 |
Apr 24/24 | Apr 4/24 | Zannes Timothy P | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 64,848 | $1.16 |
Apr 24/24 | Apr 3/24 | Girgenti Steven | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -64,848 | |
Apr 24/24 | Apr 3/24 | Girgenti Steven | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -33,438 | $2.24 |
Apr 24/24 | Apr 3/24 | Girgenti Steven | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 64,848 | $1.16 |
Mar 29/24 | Feb 16/24 | Girgenti Steven | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 39,474 | $1.52 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Lantheus Holdings (OQ:LNTH) |
Castle Biosciences (AR:CSTL) |
Myriad Genetics (OQ:MYGN) |